You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 5, MAY 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Relationship of Abnormal Vascular Responses to Retinopathy and Nephropathy in Diabetics

JØRN DITZEL, M.D.; LYNN SARGEANT, M.D.; WILLIAM B. HADLEY, M.D.

AMA Arch Intern Med. 1958;101(5):912-920.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The increasing importance of vascular disease in the diabetic is reflected in recent mortality studies. Whereas in the preinsulin era approximately 18% died of cardiorenal vascular disease, this figure had risen to 54% in 1936 and to as much as 76% in 1955.1 Furthermore, in juvenile diabetics surviving 25 to 30 years of their disease, 88% have retinopathy (46% retinitis proliferans), 39% have albuminuria, and 44% hypertension.2

Only little is known about the etiology and pathogenesis of the vascular disease. It is evident, however, that the more specific lesions, retinopathy and glomerulosclerosis, result from a slowly progressive degeneration of the smaller blood vessels. Retinopathy and glomerulosclerosis are related to various factors, including the duration of diabetes.3,4

With use of an ophthalmoscope (magnification X 15), the initial visible change found in the retinopathy of young diabetics is venous congestion (phlebopathy) and small sanguinolent dots (microaneurysms).5,6 By using . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From Baker Research Laboratory, New England Deaconess Hospital, and the Joslin Clinic and Department of Internal Medicine, Harvard University Medical School.


Footnotes

Submitted for publication Aug. 6, 1957.

This study was aided by a grant (A-H 1070C) from the National Institutes of Health, United States Public Health Service, and the Massachusetts Lions Eye Research Fund.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.